Cargando…
The Therapeutic Potential of Novel Carnosine Formulations: Perspectives for Drug Development
Carnosine (beta-alanyl-L-histidine) is an endogenous dipeptide synthesized via the activity of the ATP-dependent enzyme carnosine synthetase 1 and can be found at a very high concentration in tissues with a high metabolic rate, including muscles (up to 20 mM) and brain (up to 5 mM). Because of its w...
Autores principales: | Bonaccorso, Angela, Privitera, Anna, Grasso, Margherita, Salamone, Sonya, Carbone, Claudia, Pignatello, Rosario, Musumeci, Teresa, Caraci, Filippo, Caruso, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300694/ https://www.ncbi.nlm.nih.gov/pubmed/37375726 http://dx.doi.org/10.3390/ph16060778 |
Ejemplares similares
-
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
por: Zingale, Elide, et al.
Publicado: (2022) -
Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
por: Grasso, Margherita, et al.
Publicado: (2021) -
The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms
por: Caruso, Giuseppe, et al.
Publicado: (2023) -
The Therapeutic Potential of Carnosine as an Antidote against Drug-Induced Cardiotoxicity and Neurotoxicity: Focus on Nrf2 Pathway
por: Caruso, Giuseppe, et al.
Publicado: (2022) -
Neuroprotective Effect of Carnosine Is Mediated by
Insulin-Degrading Enzyme
por: Distefano, Alessia, et al.
Publicado: (2022)